Virtu Financial LLC Morpho Sys Ag Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024
BUY
$4.55 - $9.9 $112,112 - $243,936
24,640 New
24,640 $244,000
Q2 2023

Jul 27, 2023
BUY
$3.95 - $7.74 $53,799 - $105,418
13,620 New
13,620 $102,000
Q2 2022

Aug 09, 2022
BUY
$4.51 - $7.39 $49,835 - $81,659
11,050 New
11,050 $53,000

Others Institutions Holding MOR

# of Institutions
43
Shares Held
1.84M
Call Options Held
79.8K
Put Options Held
688K
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email